ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q2 EPS of ($3.31), $0.44 better than the analyst estimate of ($3.75).

For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.